Chemed (NYSE:CHE) Upgraded by StockNews.com to Buy

StockNews.com upgraded shares of Chemed (NYSE:CHE – Free Report) from a hold rating to a buy rating in a report published on Saturday. Several other brokerages have also recently issued reports on CHE. Royal Bank of Canada boosted their price target on shares of Chemed from $604.00 to $712.00 and gave the company an outperform […]

Related Keywords

Canada ,United States ,Brianc Judkins ,Michaeld Witzeman , ,Chemed Corporation ,Securities Exchange Commission ,Rise Advisors ,Principal Securities Inc ,Capital Advisors Inc ,Larson Financial Group ,Royal Bank ,Chemed Company Profile ,Free Report ,Get Free Report ,Exchange Commission ,Financial Group ,Chemed Daily ,Schemed ,Nyse Che ,Oche ,Medical ,16359r10 ,Upgrade ,Stocknews Com ,